- Home
- GILD vs ADP Comparison
GILD vs ADP Comparison
Compare GILD & ADP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- ADP
- Stock Information
- Founded
- GILD 1987
- ADP 1949
- Country
- GILD United States
- ADP United States
- Employees
- GILD N/A
- ADP N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- ADP EDP Services
- Sector
- GILD Health Care
- ADP Technology
- Exchange
- GILD Nasdaq
- ADP Nasdaq
- Market Cap
- GILD 129.9B
- ADP 119.7B
- IPO Year
- GILD 1992
- ADP N/A
- Fundamental
- Price
- GILD $98.16
- ADP $307.09
- Analyst Decision
- GILD Buy
- ADP Hold
- Analyst Count
- GILD 26
- ADP 11
- Target Price
- GILD $108.00
- ADP $301.91
- AVG Volume (30 Days)
- GILD 8.7M
- ADP 1.8M
- Earning Date
- GILD 04-24-2025
- ADP 04-30-2025
- Dividend Yield
- GILD 3.22%
- ADP 2.01%
- EPS Growth
- GILD 1118.07
- ADP 9.27
- EPS
- GILD 4.73
- ADP 9.78
- Revenue
- GILD $28,735,000,000.00
- ADP $20,202,600,000.00
- Revenue This Year
- GILD $1.88
- ADP $7.49
- Revenue Next Year
- GILD $3.95
- ADP $5.67
- P/E Ratio
- GILD $20.75
- ADP $31.41
- Revenue Growth
- GILD 4.68
- ADP 6.83
- 52 Week Low
- GILD $62.07
- ADP $231.27
- 52 Week High
- GILD $119.96
- ADP $322.84
- Technical
- Relative Strength Index (RSI)
- GILD 36.39
- ADP 59.87
- Support Level
- GILD $93.37
- ADP $300.93
- Resistance Level
- GILD $107.17
- ADP $305.75
- Average True Range (ATR)
- GILD 3.64
- ADP 6.20
- MACD
- GILD -0.64
- ADP 1.65
- Stochastic Oscillator
- GILD 33.76
- ADP 91.20
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About ADP Automatic Data Processing Inc.
Automatic Data Processing is a global technology company providing cloud-based human capital management solutions enabling clients to better implement payroll, talent, time, tax, and benefits administration. Additionally, ADP provides human resource outsourcing solutions that allow customers to offload some of their traditional HR tasks. The company operates through two segments: employer services and the professional employer organization services. Employer services consists of the company's HCM products as well as a la carte HRO solutions. PEO services contains ADP's comprehensive HRO solution where it acts as a co-employer with its customer. As of fiscal 2024, ADP serves over 1.1 million clients and pays over 42 million workers across 140 countries.